• No results found

University of Groningen Delivery of biologicals van Dijk, Fransien

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Delivery of biologicals van Dijk, Fransien"

Copied!
10
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Delivery of biologicals van Dijk, Fransien

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

van Dijk, F. (2018). Delivery of biologicals: Sustained release of cell-specific proteins in fibrosis. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Delivery of biologicals

Sustained release of cell-specific proteins in fibrosis

(3)

The work described in this thesis was performed at the Groningen Research Institute of Pharmacy, department of Pharmacokinetics, Toxicology & Targeting and department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands. The research project was financially supported by a grant from the Netherlands Institute of Regenerative Medicine (NIRM) and a grant from NanoNext.NL (program 03.10).

Printing of this thesis was financially supported by the University of Groningen, LinXis BV, InnoCore Pharmaceuticals and BiOrion Technologies BV.

Delivery of biologicals

Sustained release of cell-specific proteins in fibrosis

© Copyright 2018 by Fransien van Dijk. All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any means without prior permission of the author.

ISBN (printed version): 978-94-034-0509-4 ISBN (electronic version): 978-94-034-0508-7 Cover design: Jakko de Jong & Fransien van Dijk Lay-out: Fransien van Dijk

(4)

Delivery of biologicals

Sustained release of cell-specific proteins in fibrosis

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op vrijdag 23 maart 2018 om 11:00 uur

door

Fransien van Dijk

geboren op 21 oktober 1989 te Groningen

(5)

Promotores Prof. dr. K. Poelstra Prof. dr. P. Olinga Copromotores Dr. L. Beljaars Dr. W.L.J. Hinrichs Beoordelingscommissie Prof. dr. K.N. Faber Prof. dr. R. Gosens Prof. dr. J. Trebicka

(6)

Paranymphs

Eduard Post Hester Hoving

(7)
(8)

Dit proefschrift is opgedragen aan mijn Oma Sien

‘’Anyone who stops learning is old, whether at twenty or eighty. Anyone who keeps learning stays young.’’ - Henry Ford

(9)
(10)

Table of contents

Chapter 1 Introduction and aim of the thesis 10

Chapter 2 Targeted therapies in liver fibrosis: combining the best parts of 16 platelet-derived growth factor BB and interferon gamma

Chapter 3 Steering therapeutic proteins: the mechanism of action of mimetic 48 interferon gamma delivered to the disease-induced PDGFβ-receptor

Chapter 4 Polymeric microspheres for the sustained release of a protein-based 74 drug carrier targeting the PDGFβ-receptor in the fibrotic kidney

Chapter 5 Pharmacokinetics of a sustained release formulation of 104

PDGFβ-receptor directed carrier proteins to target the fibrotic liver

Chapter 6 The antifibrotic potential of a sustained release formulation of a 128 PDGFβ-receptor targeted rho kinase inhibitor

Chapter 7 Summary and general discussion 154

Chapter 8 Nederlandse samenvatting 172

Dankwoord 177

Curriculum vitae 181

Referenties

GERELATEERDE DOCUMENTEN

(1) Division of Pharmaceutical Technology and Biopharmacy, Department of Pharmacy, University of Groningen, Groningen, the Netherlands.. (2) Division of Pharmacokinetics,

The research described in this thesis was carried out at the Structural Biology Unit, Department of Drug Design (Groningen Research Institute of Pharmacy at the University

In these studies, we developed and tested a sustained release formulation based on polymeric microspheres for our model protein pPB-HSA, which is a highly versatile

Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.. Interferon gamma inhibits lipocyte activation and

In the present study we therefore studied receptor binding, intracellular routing and nuclear uptake, as well as activation of signaling pathways of Fibroferon in

The microspheres composed of the 50:50 polymer blend containing either pPB-HSA or its untargeted equivalent (HSA) demonstrated an optimal in vitro release

Subsequently, we determined in the Mdr2-/- mouse model of advanced biliary liver fibrosis how the subcutaneously injected microspheres released pPB-HSA into both

The antifibrotic effect on ECM proteins was confirmed at the protein level by immunohistochemical staining for collagen I&III, that clearly demonstrated regression